ArticleCancers2022

Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease.

Ruth Gabriela Herrera-Gómez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.